nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.133	0.218	CbGbCtD
Quetiapine—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.133	0.218	CbGbCtD
Quetiapine—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0996	0.163	CbGbCtD
Quetiapine—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0804	0.132	CbGbCtD
Quetiapine—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0648	0.106	CbGbCtD
Quetiapine—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0611	0.1	CbGbCtD
Quetiapine—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0388	0.0636	CbGbCtD
Quetiapine—HTR2A—arteriole—focal segmental glomerulosclerosis	0.00906	0.218	CbGeAlD
Quetiapine—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.00453	0.02	CcSEcCtD
Quetiapine—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.0195	CcSEcCtD
Quetiapine—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00394	0.0174	CcSEcCtD
Quetiapine—Night sweats—Cyclosporine—focal segmental glomerulosclerosis	0.00394	0.0174	CcSEcCtD
Quetiapine—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.00375	0.0166	CcSEcCtD
Quetiapine—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.0155	CcSEcCtD
Quetiapine—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.0155	CcSEcCtD
Quetiapine—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00338	0.015	CcSEcCtD
Quetiapine—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00312	0.0138	CcSEcCtD
Quetiapine—HTR7—endothelium—focal segmental glomerulosclerosis	0.00298	0.0718	CbGeAlD
Quetiapine—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.013	CcSEcCtD
Quetiapine—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.0129	CcSEcCtD
Quetiapine—Skin ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00273	0.0121	CcSEcCtD
Quetiapine—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.012	CcSEcCtD
Quetiapine—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.00254	0.0611	CbGeAlD
Quetiapine—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.0112	CcSEcCtD
Quetiapine—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.0109	CcSEcCtD
Quetiapine—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.0107	CcSEcCtD
Quetiapine—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.0107	CcSEcCtD
Quetiapine—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.0024	0.0106	CcSEcCtD
Quetiapine—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00237	0.0105	CcSEcCtD
Quetiapine—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.0104	CcSEcCtD
Quetiapine—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.0103	CcSEcCtD
Quetiapine—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.0103	CcSEcCtD
Quetiapine—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.0102	CcSEcCtD
Quetiapine—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.0101	CcSEcCtD
Quetiapine—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00228	0.0101	CcSEcCtD
Quetiapine—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00988	CcSEcCtD
Quetiapine—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00988	CcSEcCtD
Quetiapine—H1F0—nephron tubule—focal segmental glomerulosclerosis	0.00221	0.0533	CbGeAlD
Quetiapine—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.00217	0.0523	CbGeAlD
Quetiapine—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00213	0.0094	CcSEcCtD
Quetiapine—ADRA1B—kidney—focal segmental glomerulosclerosis	0.00206	0.0496	CbGeAlD
Quetiapine—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00908	CcSEcCtD
Quetiapine—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00908	CcSEcCtD
Quetiapine—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00898	CcSEcCtD
Quetiapine—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00864	CcSEcCtD
Quetiapine—H1F0—kidney—focal segmental glomerulosclerosis	0.00194	0.0469	CbGeAlD
Quetiapine—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.0085	CcSEcCtD
Quetiapine—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.0085	CcSEcCtD
Quetiapine—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.00841	CcSEcCtD
Quetiapine—H1F0—cortex of kidney—focal segmental glomerulosclerosis	0.00189	0.0456	CbGeAlD
Quetiapine—HTR2A—endothelium—focal segmental glomerulosclerosis	0.00186	0.0448	CbGeAlD
Quetiapine—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.0082	CcSEcCtD
Quetiapine—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00816	CcSEcCtD
Quetiapine—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.008	CcSEcCtD
Quetiapine—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00785	CcSEcCtD
Quetiapine—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00777	CcSEcCtD
Quetiapine—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.0077	CcSEcCtD
Quetiapine—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00763	CcSEcCtD
Quetiapine—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00763	CcSEcCtD
Quetiapine—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00759	CcSEcCtD
Quetiapine—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00171	0.00756	CcSEcCtD
Quetiapine—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00742	CcSEcCtD
Quetiapine—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00736	CcSEcCtD
Quetiapine—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.0073	CcSEcCtD
Quetiapine—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00726	CcSEcCtD
Quetiapine—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00164	0.00723	CcSEcCtD
Quetiapine—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00702	CcSEcCtD
Quetiapine—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.00699	CcSEcCtD
Quetiapine—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.00696	CcSEcCtD
Quetiapine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00682	CcSEcCtD
Quetiapine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00677	CcSEcCtD
Quetiapine—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.00672	CcSEcCtD
Quetiapine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.00672	CcSEcCtD
Quetiapine—HTR1D—kidney—focal segmental glomerulosclerosis	0.00151	0.0363	CbGeAlD
Quetiapine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00646	CcSEcCtD
Quetiapine—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00639	CcSEcCtD
Quetiapine—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00626	CcSEcCtD
Quetiapine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00623	CcSEcCtD
Quetiapine—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00617	CcSEcCtD
Quetiapine—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00615	CcSEcCtD
Quetiapine—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.00604	CcSEcCtD
Quetiapine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00602	CcSEcCtD
Quetiapine—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00594	CcSEcCtD
Quetiapine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.0059	CcSEcCtD
Quetiapine—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.00578	CcSEcCtD
Quetiapine—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00567	CcSEcCtD
Quetiapine—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00565	CcSEcCtD
Quetiapine—CHRM3—kidney—focal segmental glomerulosclerosis	0.00126	0.0304	CbGeAlD
Quetiapine—ADRA2C—nephron tubule—focal segmental glomerulosclerosis	0.00126	0.0302	CbGeAlD
Quetiapine—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00125	0.00552	CcSEcCtD
Quetiapine—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00548	CcSEcCtD
Quetiapine—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00545	CcSEcCtD
Quetiapine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00537	CcSEcCtD
Quetiapine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00534	CcSEcCtD
Quetiapine—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00532	CcSEcCtD
Quetiapine—HTR7—kidney—focal segmental glomerulosclerosis	0.0012	0.0289	CbGeAlD
Quetiapine—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00529	CcSEcCtD
Quetiapine—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00526	CcSEcCtD
Quetiapine—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00526	CcSEcCtD
Quetiapine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00524	CcSEcCtD
Quetiapine—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00513	CcSEcCtD
Quetiapine—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00513	CcSEcCtD
Quetiapine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00511	CcSEcCtD
Quetiapine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00511	CcSEcCtD
Quetiapine—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00497	CcSEcCtD
Quetiapine—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00496	CcSEcCtD
Quetiapine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00493	CcSEcCtD
Quetiapine—ADRA2C—kidney—focal segmental glomerulosclerosis	0.0011	0.0266	CbGeAlD
Quetiapine—ADRA2C—cortex of kidney—focal segmental glomerulosclerosis	0.00107	0.0259	CbGeAlD
Quetiapine—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00475	CcSEcCtD
Quetiapine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00473	CcSEcCtD
Quetiapine—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00472	CcSEcCtD
Quetiapine—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.00472	CcSEcCtD
Quetiapine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0047	CcSEcCtD
Quetiapine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00469	CcSEcCtD
Quetiapine—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00466	CcSEcCtD
Quetiapine—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.00105	0.0253	CbGeAlD
Quetiapine—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00464	CcSEcCtD
Quetiapine—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00463	CcSEcCtD
Quetiapine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00455	CcSEcCtD
Quetiapine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000995	0.0044	CcSEcCtD
Quetiapine—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000968	0.00428	CcSEcCtD
Quetiapine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000962	0.00425	CcSEcCtD
Quetiapine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000958	0.00424	CcSEcCtD
Quetiapine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000935	0.00414	CcSEcCtD
Quetiapine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000929	0.00411	CcSEcCtD
Quetiapine—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000923	0.0222	CbGeAlD
Quetiapine—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000916	0.00405	CcSEcCtD
Quetiapine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000912	0.00403	CcSEcCtD
Quetiapine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00091	0.00402	CcSEcCtD
Quetiapine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000902	0.00399	CcSEcCtD
Quetiapine—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000899	0.0217	CbGeAlD
Quetiapine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000893	0.00395	CcSEcCtD
Quetiapine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000876	0.00387	CcSEcCtD
Quetiapine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000871	0.00385	CcSEcCtD
Quetiapine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000862	0.00381	CcSEcCtD
Quetiapine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000859	0.0038	CcSEcCtD
Quetiapine—ADRA2A—cortex of kidney—focal segmental glomerulosclerosis	0.000857	0.0207	CbGeAlD
Quetiapine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000854	0.00378	CcSEcCtD
Quetiapine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000849	0.00376	CcSEcCtD
Quetiapine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000838	0.00371	CcSEcCtD
Quetiapine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000835	0.00369	CcSEcCtD
Quetiapine—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000832	0.00368	CcSEcCtD
Quetiapine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000811	0.00359	CcSEcCtD
Quetiapine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000805	0.00356	CcSEcCtD
Quetiapine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000802	0.00355	CcSEcCtD
Quetiapine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000791	0.0035	CcSEcCtD
Quetiapine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000791	0.0035	CcSEcCtD
Quetiapine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000791	0.0035	CcSEcCtD
Quetiapine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000788	0.00349	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000786	0.00347	CcSEcCtD
Quetiapine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000782	0.00346	CcSEcCtD
Quetiapine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000774	0.00342	CcSEcCtD
Quetiapine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000765	0.00338	CcSEcCtD
Quetiapine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000758	0.00335	CcSEcCtD
Quetiapine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000753	0.00333	CcSEcCtD
Quetiapine—HTR2A—kidney—focal segmental glomerulosclerosis	0.000748	0.018	CbGeAlD
Quetiapine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000744	0.00329	CcSEcCtD
Quetiapine—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000742	0.00328	CcSEcCtD
Quetiapine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000737	0.00326	CcSEcCtD
Quetiapine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000733	0.00324	CcSEcCtD
Quetiapine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000723	0.0032	CcSEcCtD
Quetiapine—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000693	0.0167	CbGeAlD
Quetiapine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000691	0.00306	CcSEcCtD
Quetiapine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000686	0.00303	CcSEcCtD
Quetiapine—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000682	0.0164	CbGeAlD
Quetiapine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000681	0.00301	CcSEcCtD
Quetiapine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000676	0.00299	CcSEcCtD
Quetiapine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000674	0.00298	CcSEcCtD
Quetiapine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000668	0.00295	CcSEcCtD
Quetiapine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000659	0.00292	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000655	0.0029	CcSEcCtD
Quetiapine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000654	0.00289	CcSEcCtD
Quetiapine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000648	0.00287	CcSEcCtD
Quetiapine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000648	0.00287	CcSEcCtD
Quetiapine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000625	0.00276	CcSEcCtD
Quetiapine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00062	0.00274	CcSEcCtD
Quetiapine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000599	0.00265	CcSEcCtD
Quetiapine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000599	0.00265	CcSEcCtD
Quetiapine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000559	0.00247	CcSEcCtD
Quetiapine—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000558	0.0134	CbGeAlD
Quetiapine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000544	0.00241	CcSEcCtD
Quetiapine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000537	0.00237	CcSEcCtD
Quetiapine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000519	0.00229	CcSEcCtD
Quetiapine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000501	0.00222	CcSEcCtD
Quetiapine—ABCB1—kidney—focal segmental glomerulosclerosis	0.00049	0.0118	CbGeAlD
Quetiapine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000482	0.00213	CcSEcCtD
Quetiapine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000478	0.00211	CcSEcCtD
Quetiapine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000478	0.00211	CcSEcCtD
Quetiapine—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000478	0.0115	CbGeAlD
Quetiapine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000475	0.0021	CcSEcCtD
Quetiapine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00045	0.00199	CcSEcCtD
Quetiapine—Olanzapine—ALB—focal segmental glomerulosclerosis	0.000196	0.268	CrCbGaD
Quetiapine—Thioproperazine—ALB—focal segmental glomerulosclerosis	0.000181	0.247	CrCbGaD
Quetiapine—Thiothixene—ALB—focal segmental glomerulosclerosis	0.000178	0.243	CrCbGaD
Quetiapine—Pipotiazine—ALB—focal segmental glomerulosclerosis	0.000178	0.243	CrCbGaD
Quetiapine—CHRM5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.13e-05	0.000258	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.12e-05	0.000257	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.11e-05	0.000257	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.11e-05	0.000257	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.11e-05	0.000256	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.11e-05	0.000256	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.1e-05	0.000255	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.1e-05	0.000255	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	3.09e-05	0.000255	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.09e-05	0.000255	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.09e-05	0.000255	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.06e-05	0.000252	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.05e-05	0.000251	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.05e-05	0.000251	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.04e-05	0.00025	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.03e-05	0.00025	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.01e-05	0.000248	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3e-05	0.000248	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.98e-05	0.000246	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	2.97e-05	0.000245	CbGpPWpGaD
Quetiapine—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.95e-05	0.000243	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.94e-05	0.000243	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.94e-05	0.000243	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.93e-05	0.000241	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.91e-05	0.00024	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.9e-05	0.000239	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.88e-05	0.000238	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	2.88e-05	0.000238	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.88e-05	0.000237	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.88e-05	0.000237	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.87e-05	0.000237	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.87e-05	0.000236	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.86e-05	0.000236	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.86e-05	0.000235	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.86e-05	0.000235	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.86e-05	0.000235	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.85e-05	0.000235	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.85e-05	0.000235	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.84e-05	0.000234	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.83e-05	0.000234	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.83e-05	0.000234	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.81e-05	0.000231	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.8e-05	0.000231	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.8e-05	0.00023	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.75e-05	0.000227	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.74e-05	0.000226	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	2.72e-05	0.000224	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.71e-05	0.000224	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.71e-05	0.000223	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.71e-05	0.000223	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.66e-05	0.000219	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.66e-05	0.000219	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.66e-05	0.000219	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.66e-05	0.000219	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.65e-05	0.000219	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.64e-05	0.000218	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.61e-05	0.000216	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.61e-05	0.000215	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.6e-05	0.000214	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.6e-05	0.000214	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.6e-05	0.000214	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.59e-05	0.000214	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.58e-05	0.000213	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.58e-05	0.000213	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.57e-05	0.000212	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.57e-05	0.000212	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.56e-05	0.000211	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.55e-05	0.00021	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—LPL—focal segmental glomerulosclerosis	2.55e-05	0.00021	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.54e-05	0.00021	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	2.54e-05	0.000209	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.51e-05	0.000207	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	2.5e-05	0.000206	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.49e-05	0.000205	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.48e-05	0.000205	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.48e-05	0.000204	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.48e-05	0.000204	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.48e-05	0.000204	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	2.46e-05	0.000203	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.44e-05	0.000201	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.44e-05	0.000201	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.44e-05	0.000201	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.44e-05	0.000201	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.44e-05	0.000201	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.41e-05	0.000199	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.4e-05	0.000198	CbGpPWpGaD
Quetiapine—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	2.4e-05	0.000198	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	2.39e-05	0.000197	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.38e-05	0.000196	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.37e-05	0.000195	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.36e-05	0.000194	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.35e-05	0.000193	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	2.34e-05	0.000193	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.33e-05	0.000192	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.29e-05	0.000189	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.28e-05	0.000188	CbGpPWpGaD
Quetiapine—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.27e-05	0.000187	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.26e-05	0.000186	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.26e-05	0.000186	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.25e-05	0.000186	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.25e-05	0.000185	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.22e-05	0.000183	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.21e-05	0.000182	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.21e-05	0.000182	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.21e-05	0.000182	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.21e-05	0.000182	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.2e-05	0.000182	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.2e-05	0.000182	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	2.2e-05	0.000181	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.2e-05	0.000181	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2.2e-05	0.000181	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.2e-05	0.000181	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.19e-05	0.00018	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—AGT—focal segmental glomerulosclerosis	2.18e-05	0.00018	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.18e-05	0.000179	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.17e-05	0.000179	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.15e-05	0.000177	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.15e-05	0.000177	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.15e-05	0.000177	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.15e-05	0.000177	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	2.14e-05	0.000177	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.14e-05	0.000176	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.13e-05	0.000176	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.13e-05	0.000176	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.12e-05	0.000175	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.12e-05	0.000174	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.11e-05	0.000174	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.11e-05	0.000174	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.09e-05	0.000172	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.07e-05	0.000171	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.06e-05	0.00017	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	2.04e-05	0.000169	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.04e-05	0.000168	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.04e-05	0.000168	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.03e-05	0.000168	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.03e-05	0.000167	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.03e-05	0.000167	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.03e-05	0.000167	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.02e-05	0.000167	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.02e-05	0.000166	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	2e-05	0.000165	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2e-05	0.000165	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2e-05	0.000165	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.99e-05	0.000164	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.97e-05	0.000162	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.96e-05	0.000161	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.96e-05	0.000161	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	1.95e-05	0.000161	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.9e-05	0.000157	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.9e-05	0.000157	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	1.89e-05	0.000156	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.88e-05	0.000155	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.88e-05	0.000155	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.87e-05	0.000155	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.87e-05	0.000154	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.85e-05	0.000153	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.84e-05	0.000152	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.84e-05	0.000151	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	1.83e-05	0.000151	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.83e-05	0.000151	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.82e-05	0.00015	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.81e-05	0.000149	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.81e-05	0.000149	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.8e-05	0.000149	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.73e-05	0.000142	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.7e-05	0.00014	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.7e-05	0.00014	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.7e-05	0.00014	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.69e-05	0.00014	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.69e-05	0.00014	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.69e-05	0.000139	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.69e-05	0.000139	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.68e-05	0.000139	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—ALB—focal segmental glomerulosclerosis	1.67e-05	0.000138	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.67e-05	0.000138	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.67e-05	0.000138	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.66e-05	0.000137	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	1.66e-05	0.000137	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.65e-05	0.000136	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.64e-05	0.000135	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.63e-05	0.000135	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.63e-05	0.000134	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.62e-05	0.000134	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	1.62e-05	0.000133	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.6e-05	0.000132	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.58e-05	0.000131	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.56e-05	0.000129	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.55e-05	0.000128	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	1.54e-05	0.000127	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.53e-05	0.000126	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.52e-05	0.000126	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.46e-05	0.00012	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.44e-05	0.000119	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.44e-05	0.000119	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.44e-05	0.000119	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.44e-05	0.000119	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	1.42e-05	0.000117	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.41e-05	0.000117	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.41e-05	0.000116	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	1.41e-05	0.000116	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.41e-05	0.000116	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.4e-05	0.000116	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.4e-05	0.000115	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.4e-05	0.000115	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.39e-05	0.000115	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.39e-05	0.000114	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.39e-05	0.000114	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	1.38e-05	0.000114	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.36e-05	0.000112	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.34e-05	0.00011	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.33e-05	0.000109	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.32e-05	0.000109	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.3e-05	0.000108	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.3e-05	0.000107	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.29e-05	0.000106	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.26e-05	0.000104	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.25e-05	0.000103	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.25e-05	0.000103	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.21e-05	0.0001	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.2e-05	9.91e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.19e-05	9.85e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.19e-05	9.78e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.19e-05	9.78e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.1e-05	9.08e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	1.09e-05	8.97e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.08e-05	8.93e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.08e-05	8.91e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.08e-05	8.89e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.07e-05	8.86e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.07e-05	8.83e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.06e-05	8.77e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	1.06e-05	8.76e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.06e-05	8.75e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.03e-05	8.52e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.03e-05	8.48e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	1e-05	8.25e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1e-05	8.25e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	9.97e-06	8.22e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.86e-06	8.13e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.85e-06	8.12e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.08e-06	7.48e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.93e-06	7.36e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.91e-06	7.35e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.88e-06	7.32e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.85e-06	7.3e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.77e-06	7.23e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.74e-06	7.21e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	8.53e-06	7.03e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.13e-06	6.7e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	6.55e-06	5.4e-05	CbGpPWpGaD
